Lv41
490 积分 2022-11-14 加入
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
42分钟前
待确认
Triptorelin in the Treatment of Prostate Cancer
13天前
已关闭
Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis
17天前
已完结
Second-line treatment options in metastatic castration-resistant prostate cancer after progression on first-line androgen-receptor targeting therapies: A systematic review and Bayesian network analysis
17天前
已完结
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial
25天前
已完结
Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study
25天前
已完结
Rapid and Deep Prostate‐Specific Antigen Decline is a Prognostic Marker in Metastatic Hormone‐Sensitive Prostate Cancer: A Real‐World Multi‐Intuitional Analysis
28天前
已完结
Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
28天前
已完结
Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data
1个月前
已完结
Randomized Phase 2 Trial of Presurgical Androgen Deprivation Therapy With or Without Axitinib in Prostate Cancer Presenting With Lymph Node Metastasis
1个月前
已完结
皖公网安备34019202002308
